Form 8-K - Current report:
SEC Accession No. 0001628280-18-012030
Filing Date
2018-09-21
Accepted
2018-09-21 17:16:01
Documents
1
Period of Report
2018-09-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K 5.02 NEW DIRECTOR newdirector092120188-kdocu.htm 8-K 24062
  Complete submission text file 0001628280-18-012030.txt   25199
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 181082181
SIC: 2834 Pharmaceutical Preparations